Succination inactivates gasdermin D and blocks pyroptosis
Activated macrophages undergo a metabolic switch to aerobic glycolysis, accumulating
Krebs’ cycle intermediates that alter transcription of immune response genes. We extended …
Krebs’ cycle intermediates that alter transcription of immune response genes. We extended …
[PDF][PDF] Critical role of histone turnover in neuronal transcription and plasticity
…, I Purushothaman, SJ Elsässer, Y Guo, C Ionete… - Neuron, 2015 - cell.com
Turnover and exchange of nucleosomal histones and their variants, a process long believed
to be static in post-replicative cells, remains largely unexplored in brain. Here, we describe …
to be static in post-replicative cells, remains largely unexplored in brain. Here, we describe …
Neuroinflammatory component of gray matter pathology in multiple sclerosis
Objective In multiple sclerosis (MS), using simultaneous magnetic resonance–positron
emission tomography (MR‐PET) imaging with 11 C‐PBR28, we quantified expression of the …
emission tomography (MR‐PET) imaging with 11 C‐PBR28, we quantified expression of the …
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity
…, BM Greenberg, DA Hafler, C Ionete… - Proceedings of the …, 2023 - National Acad Sciences
A small proportion of multiple sclerosis (MS) patients develop new disease activity soon
after starting anti-CD20 therapy. This activity does not recur with further dosing, possibly …
after starting anti-CD20 therapy. This activity does not recur with further dosing, possibly …
[HTML][HTML] COVID-19 in teriflunomide-treated patients with multiple sclerosis
AH Maghzi, MK Houtchens, P Preziosa, C Ionete… - Journal of …, 2020 - Springer
The outbreak of a severe acute respiratory syndrome caused by a novel coronavirus (COVID-19),
has raised health concerns for patients with multiple sclerosis (MS) who are commonly …
has raised health concerns for patients with multiple sclerosis (MS) who are commonly …
[HTML][HTML] Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223
…, R Berkovich, M Carraro, Ó Fernández, C Ionete… - Journal of …, 2020 - Springer
Background In the phase 2 CAMMS223 trial (NCT00050778), alemtuzumab significantly
improved clinical and MRI outcomes versus subcutaneous interferon beta-1a over 3 years in …
improved clinical and MRI outcomes versus subcutaneous interferon beta-1a over 3 years in …
Paramagnetic rim lesions are associated with pathogenic CSF profiles and worse clinical status in multiple sclerosis: A retrospective cross-sectional study
Background: Paramagnetic rims have been observed as a feature of some multiple sclerosis
(MS) lesions on susceptibility-sensitive magnetic resonance imaging (MRI) and indicate …
(MS) lesions on susceptibility-sensitive magnetic resonance imaging (MRI) and indicate …
The varieties of psychosis in multiple sclerosis: a systematic review of cases
…, I Berrios-Morales, C Ionete… - Multiple sclerosis and …, 2017 - Elsevier
Objectives Multiple Sclerosis (MS) is known to be associated with a wide range of psychiatric
symptoms, particularly with affective disorders. However, a link to psychotic disorders has …
symptoms, particularly with affective disorders. However, a link to psychotic disorders has …
JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis
…, RP Kinkel, JA Sloane, M Donnelly, C Ionete… - Annals of …, 2014 - Wiley Online Library
Objective To determine the prevalence of JC virus (JCV) reactivation and JCV‐specific
cellular immune response during prolonged natalizumab treatment for multiple sclerosis (MS). …
cellular immune response during prolonged natalizumab treatment for multiple sclerosis (MS). …
Relationships between multiple sclerosis and depression
…, AJ Rothschild, P Riskind, C Ionete… - The Journal of …, 2011 - Am Neuropsych Assoc
The authors' findings suggest that major depressive disorder (MDD) may occur as a prodrome
to and may delay diagnosis of multiple sclerosis (MS). Lifetime prevalence of MDD was 59…
to and may delay diagnosis of multiple sclerosis (MS). Lifetime prevalence of MDD was 59…